Broedrene Hartmann A/S
XBER:CQ5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Broedrene Hartmann A/S
XBER:CQ5
|
DK |
|
X T L Biopharmaceuticals Ltd
F:H2K2
|
IL |
|
R
|
Robertet SA
PAR:CBE
|
FR |
|
Aris Gold Corp
F:ZP1
|
CA |
|
Big Tree Carbon Inc
F:L6X
|
CA |
|
Aduro Clean Technologies Inc
OTC:ACTHF
|
CA |
|
Core Critical Metals Corp
XTSX:CCMC
|
CA |
|
CGG SA
F:GDGF
|
FR |
|
Asia Sejahtera Mina Tbk PT
IDX:AGAR
|
ID |
|
Boss Energy Ltd
F:B8Y
|
AU |
|
P
|
Press Ventures Inc
OTC:PVEN
|
PL |
|
Ecopro Co Ltd
KOSDAQ:086520
|
KR |
|
Z
|
Zen Voce Corp
TPEX:3581
|
TW |
|
Europacorp SA
LSE:0IB7
|
FR |
|
AECI Ltd
F:A7Z
|
ZA |
|
Z
|
Zhejiang Daily Digital Culture Group Co Ltd
SSE:600633
|
CN |
|
Emaar The Economic City SJSC
SAU:4220
|
SA |
|
Ondeck Co Ltd
TSE:7360
|
JP |
|
GL Sciences Inc
TSE:7705
|
JP |
|
Protean Energy Ltd
F:SHE1
|
AU |
|
Xinyi Solar Holdings Ltd
F:13X
|
CN |
|
H
|
Hygrovest Ltd
F:2P9A
|
AU |
|
S
|
Strategic Metals Ltd
OTC:SMDZF
|
CA |
|
M
|
Molinos Rio de la Plata SA
BCBA:MOLI5
|
AR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CQ5's stock price target?
Not Available
CQ5 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Broedrene Hartmann A/S?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for Broedrene Hartmann A/S?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 24%.